Warner Chilcott Reports Operating Results for the Quarter Ended Septembe...(and to better compare the Company's fina...),Health

Adjusted EBITDA

To supplement its condensed consolidated financial statements presented in accordance with US GAAP, the Company is providing a summary to show the computation of adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") taking into account certain charges that were taken during the quarter and nine months ended September 30, 2007 and 2006. The computation of adjusted EBITDA is based on the definition of EBITDA contained in the indenture governing the Company's 8.75% Senior Subordinated Notes due 2015.

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

Quarter Ended Nine Months Ended

Sept-30-07 Sept-30-06 Sept-30-07 Sept-30-06

REVENUE:

Product net sales $223,670 $194,668 $663,625 $548,099

Other revenue 2,794 - 8,233 -

Total revenue 226,464 194,668 671,858 548,099

COSTS & EXPENSES:

Cost of sales (excludes

amortization) 45,490 39,186 142,383 108,204

Selling, general and

administrative 60,760 99,671 208,808 198,978

Research and development 24,093 4,794 42,763 19,451

Amortization of intangible

assets 57,054 63,151 172,161 185,125

Interest income (895) (1,721) (3,928) (2,506)

Intere
'/>"/>